Sign in to view content

Treatment Effect of Intravitreal Aflibercept Injection by Baseline Factors in Moderately Severe-to-Severe NPDR in PANORAMA

Nathan C. Steinle, MD

Video
Published 2020

Related

The Impact of Social Determinants of Health on Eye Care Utilization in a National Sample of People With Diabetes
Cindy X Cai, MD
Annual Meeting Talks
2024
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Week 48 Efficacy Outcomes by Baseline Demographics in the Phase 2/3 PHOTON Trial
Andres Emanuelli, MD
Annual Meeting Talks
2023
Risk of Diabetic Retinopathy Progression in Patients During 1 year of Semaglutide Use
Blake A. Cooper, MD MPH
Updates from the Field
2022

Category: Diabetic Retinopathy

See more